Bengaluru-headquartered biopharmaceuticals company Biocon Ltd has moved up to sixth spot in the Top 10 Global Biotech Employers ranking for 2019.
It continues to be the only company from Asia to feature on the prestigious US-based 'Science' magazine's annual 'Science Careers Top 20 Employers' list, since its debut in 2012.
Ranked at number six among global pharma and biotech companies in 2019, Biocon has moved up from number seven in 2018 and number nine in 2017.
Biocon said in a statement it has been consistently recognised for three key attributes: "Innovative leader in the industry, 'is socially responsible' and leadership makes changes needed."
The ranking is a result of the 2019 Science Careers Top Employers global survey conducted by the US-based Science magazine to determine which companies in the biotech and pharmaceutical industry have the best reputations as employers globally.
Kiran Mazumdar Shaw, CMD, Biocon said: "We have consciously created a culture that encourages ideation, experimentation and collaboration to address unmet patient needs."
Biocon was ahead of leading global pharma companies like Novozymes, Roche, Eli Lilly, Abbott, Novartis, Pfizer etc. in the 2019 rankings.
The Top 5 global players in this year's list are Alnylam, Regeneron, Incyte, Merck KGaA and Spark therapeutics.
Respondents to the web-based survey were asked to rate companies based on 23 characteristics, including 'innovative leader in the industry,' 'treating employees with respect,' 'is socially responsible,' 'work culture values aligned' and 'leadership makes changes needed,' it was stated.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)